Drug Trial Radar · NCT00406887
Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis
Last checked: Nov 20, 2026Latest source record: Dec 4, 2006 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
140
Actual
Start
Aug 2002
Primary completion
Not stated
Study completion Nov 2003
Sponsor
- Lead sponsor
- Sirion Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Dec 4, 2006
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this phase 3 confirmatory study is to determine if difluprednate ophthalmic emulsion is effective in the treatment of treatment of uveitis.
Conditions
- Anterior Uveitis
- Panuveitis
Interventions
Difluprednate Ophthalmic EmulsionDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- The difference from the baseline in anterior chamber cell score on Day 14
- was compared between the two groups.
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.